eli lilly tirzepatide trial Lilly's Zepbound available in two vials for self-pay patients Tirzepatide gets a big win

Scientific research supports the efficacy of ketogenic diets in weight management and metabolic health

FDA approves Ozempic for type 2 diabetes

Novo Nordisk has said that CagriSema is well-tolerated, and the most common adverse events were gastrointestinal (GI) related

It also remains unclear which patients may show limited response, persistent appetite, weight regain, or paradoxical appetite responses despite treatment

Neural Biomarkers and Food Preoccupation Obesity and related metabolic disorders often involve distressing preoccupation with food, which can lead to loss-of-control eating or binge-like episodes

Richness of human gut microbiome correlates with metabolic markers (in Eng)